Arkolith/Insider Trading/BDTX/Form 4

Biotech Growth N V

10% OwnerBlack Diamond Therapeutics, Inc. (BDTX) · full profile →Form 4 · filed Oct 19, 2023
Net Buying
Open-Market Buys
$936K
Open-Market Sells
$0
Net Open-Market Flow
$936K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 17, 2023Buy(P)400K$2.34$936K8.5M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-23-054142) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML